DGAP-News: Epigenomics AG / Key word(s): Product Launch 02.07.2018 / 07:40 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Liquid Biopsy Test for Liver Cancer Detection to obtain CE Mark – Epigenomics plans to CE Mark mSEPT9 blood test for liver cancer by year-end 2018, enabling commercialization in […]
Author: mark
02. July 2018
Epigenomics AG: Liquid Biopsy Test for Liver Cancer Detection to obtain CE Mark
Read more
11. June 2018
Epigenomics AG: Centers for Medicare & Medicaid Services publish preliminary rate for Epigenomics’ colorectal cancer screening test Epi proColon(R)
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 11.06.2018 / 08:37 The issuer is solely responsible for the content of this announcement. Press release Centers for Medicare & Medicaid Services publish preliminary rate for Epigenomics’ colorectal cancer screening test Epi proColon(R) Medicare Administrative Contractors determine rate of $192 per test Berlin (Germany) and Germantown, MD (U.S.A.), […]
09. May 2018
Epigenomics AG announces 2018 First Quarter Financial Results
DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 09.05.2018 / 08:20 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG announces 2018 First Quarter Financial Results Berlin (Germany) and Germantown, MD (U.S.A.), May 9, 2018 – Epigenomics AG (FSE: ECX, OTCQX: EPGNY), or the “Company”, today announced […]
19. April 2018
Epigenomics AG: Blood test shows promise in the detection of liver cancer
DGAP-News: Epigenomics AG / Key word(s): Study results 19.04.2018 / 06:40 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG: Blood test shows promise in the detection of liver cancer – Results from two clinical studies demonstrate high sensitivity and specificity of mSEPT9 blood test – mSEPT9 test exhibited […]
23. March 2018
Epigenomics AG Reports Results for Financial Year 2017
DGAP-News: Epigenomics AG / Key word(s): Final Results 23.03.2018 / 08:20 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Reports Results for Financial Year 2017 Berlin (Germany) and Germantown, MD (U.S.A.), March 23, 2018 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY), or the “Company”, today announced […]
08. March 2018
Epigenomics AG: U.S. Senators Capito and Heinrich Introduce Bi-Partisan Colorectal Cancer Detection Bill
DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 08.03.2018 / 22:30 The issuer is solely responsible for the content of this announcement. Press release U.S. Senators Capito and Heinrich Introduce Bi-Partisan Colorectal Cancer Detection Bill Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests Berlin (Germany) and Germantown, […]